This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bright Peak Therapeutics Ag. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Andrew Chi - Innovator in Immunocytokine Research
Introduction
Andrew Chi is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of immunocytokines, particularly through his innovative research and development efforts. His work focuses on enhancing immune responses through targeted therapies.
Latest Patents
Andrew Chi holds a patent for "Immune antigen specific IL-18 immunocytokines and uses thereof." This patent relates to modified immunocytokine compositions that comprise antibodies or antigen-binding fragments specific for immune cell antigens and IL-18 polypeptides. The patent also outlines methods of treatment and manufacture of these immunocytokine compositions. He has 1 patent to his name.
Career Highlights
Chi is currently associated with Bright Peak Therapeutics, a company dedicated to advancing immunotherapy solutions. His role involves leveraging his expertise to develop innovative treatments that can significantly impact patient care.
Collaborations
Andrew Chi has collaborated with notable colleagues, including Vijaya Raghavan Pattabiraman and Bertolt Kreft. These collaborations have further enriched his research and contributed to advancements in the field.
Conclusion
Andrew Chi's work in immunocytokine research exemplifies the innovative spirit of modern science. His contributions are paving the way for new therapeutic approaches in immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile